Literature DB >> 31680014

Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval.

Erick H Turner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31680014     DOI： 10.1016/S2215-0366(19)30394-3

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  25 in total

1.  Brain-derived neurotrophic factor-TrkB signaling and the mechanism of antidepressant activity by ketamine in mood disorders.

Authors:  Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03       Impact factor: 5.270

Review 2.  Mechanisms of ketamine and its metabolites as antidepressants.

Authors:  Evan M Hess; Lace M Riggs; Michael Michaelides; Todd D Gould
Journal:  Biochem Pharmacol       Date:  2021-12-27       Impact factor: 5.858

Review 3.  Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.

Authors:  Rebecca L Dean; Claudia Hurducas; Keith Hawton; Styliani Spyridi; Philip J Cowen; Sarah Hollingsworth; Tahnee Marquardt; Annabelle Barnes; Rebecca Smith; Rupert McShane; Erick H Turner; Andrea Cipriani
Journal:  Cochrane Database Syst Rev       Date:  2021-09-12

Review 4.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

5.  Structural basis of ketamine action on human NMDA receptors.

Authors:  Youyi Zhang; Fei Ye; Tongtong Zhang; Shiyun Lv; Liping Zhou; Daohai Du; He Lin; Fei Guo; Cheng Luo; Shujia Zhu
Journal:  Nature       Date:  2021-07-28       Impact factor: 49.962

Review 6.  "Novel Psychopharmacology for Depressive Disorders".

Authors:  Michele Fornaro; Domenico De Berardis; Annalisa Anastasia; Andrea Fusco
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications.

Authors:  Zezhi Li; Meihua Ruan; Jun Chen; Yiru Fang
Journal:  Neurosci Bull       Date:  2021-02-13       Impact factor: 5.203

8.  Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers.

Authors:  Dmitriy Matveychuk; Rejish K Thomas; Jennifer Swainson; Atul Khullar; Mary-Anne MacKay; Glen B Baker; Serdar M Dursun
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-11

Review 9.  Orphan G Protein Coupled Receptors in Affective Disorders.

Authors:  Lyndsay R Watkins; Cesare Orlandi
Journal:  Genes (Basel)       Date:  2020-06-24       Impact factor: 4.096

10.  Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery.

Authors:  Aaron J Courtenay; Emma McAlister; Maelíosa T C McCrudden; Lalit Vora; Lilach Steiner; Galit Levin; Etgar Levy-Nissenbaum; Nava Shterman; Mary-Carmel Kearney; Helen O McCarthy; Ryan F Donnelly
Journal:  J Control Release       Date:  2020-03-19       Impact factor: 9.776
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.